3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
33
Breast Neoplasms
25
Rectal Neoplasms
23
Esophageal Neoplasms
22
Stomach Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
18
Glioblastoma
16
Pancreatic Neoplasms
14
Lung Neoplasms
14
Head and Neck Neoplasms
12
Colorectal Neoplasms
11
Sarcoma
10
Brain Neoplasms
10
Neoplasms
9
Colonic Neoplasms
8
Adenocarcinoma Of Esophagus
7
Melanoma
6
Glioma
6
Esophageal Squamous Cell Carcinoma
6
Ovarian Neoplasms
5
Oropharyngeal Neoplasms
5
Hypopharyngeal Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Adenocarcinoma of Lung
5
Prostatic Neoplasms
4
Mouth Neoplasms
4
Gliosarcoma
4
Fallopian Tube Neoplasms
4
Central Nervous System Neoplasms
4
Carcinoma, Squamous Cell
4
Interventions
Oxaliplatin
2
130-nm albumin-bound paclitaxel
2
irinotecan sucrosofate
1
folfirinox
1
camrelizumab
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Leucovorin
1
Gemcitabine
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Borderline Resectable Pancreatic Cancer
×
Surgical Procedures, Operative
×
Clear all
NCT06387810
2024-07-10
undetermined
Peking Union Medical College Hospital
Phase 2
Recruiting
45 enrolled